Neurocrine Biosciences Inc Voyager Therapeutics, Inc. (VYGR) insider trading activity
Neurocrine Biosciences Inc is > 10% Shareholder of Voyager Therapeutics, Inc.. Currently has a direct ownership of 8.58 Million shares of VYGR, which is worth approximately $50.7 Million. The most recent transaction as insider was on Feb 23, 2023, when has been sold 4,395,588 shares (Common Stock) at a price of $8.88 per share, resulting in proceeds of $39,032,821. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
8.58M
0%
3M change
0%
12M change
Total Value Held
$50.7 Million
NBI
Neurocrine Biosciences Inc
> 10% Shareholder
San Diego, CA